Esophageal cancer is esophageal cancer, and there is no authoritative information on the survival period of recurrent metastasis of esophageal cancer. Clinically, the five-year survival rate is generally used to indicate the survival period of esophageal cancer patients, and the five-year survival rates of stage 0, stage I, stage IIa, stage IIb, stage III and stage IV are 100%, 90%, 70%-85%, 45%-67%, 15%-20% and 10% respectively. When esophageal cancer patients have recurrence, the survival period of patients cannot be judged accurately, and the five-year survival rate of patients needs to be judged according to their specific conditions. If the patient with recurrence of esophageal cancer is in stage 0, the five-year survival rate is 100%. If a patient with esophageal cancer is in stage I, the five-year survival rate is above 90%. If the patient is in stage IIa, the five-year survival rate is 70% to 85%. If the patient is in stage IIb, the five-year survival rate is 45% to 67%, the five-year survival rate of stage III is 15% to 20%, and the five-year survival rate of stage IV is less than 10%. There is no authoritative clinical data on the survival period of patients with recurrence of esophageal cancer, patients should consult doctor in time and take treatment measures according to doctor’s advice.